Locations:
SearchHighlights from the 2014 Medical Innovation Summit
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
In the past, oncologists classified tumors based on where they originated in the body. But cancers arising in different anatomic locations may share genomic abnormalities. Cleveland Clinic Taussig Cancer Institute Chairman Brian Bolwell, MD, discusses how personalized medicine will require a rethinking of cancer classification.
Advertisement
Advertisement
Timing and type of side effects differ greatly from chemotherapy
Dedicated multidisciplinary teams support 84 ultra-rare cancers
Sessions explore treatment advances and multidisciplinary care
New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues
Combination of olaparib and carboplatin results in complete durable response for a patient with BRCA2 and “BRCAness” mutations
Early communication between oncologists and ophthalmologist warranted
Case-based course delves into latest treatment approaches
Long-term relationship building and engagement key to gaining community trust